Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$538,100
-3.11%
Shares
Shares Volume: 10,000 Shares
Average Share Price: $53.81
INSIDER
Young Jonathan
Chief Operating Officer (Officer)
reported on Feb 5 2025
traded on Feb 3 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 311,147 |
| PURCHASES/SALES 1Y | 0 / 15 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $341,152.79 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 5 |
| PURCHASES/SALES 1Y | 0 / 52 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $711,287.97 |
| COMPANY PREVIOUS TRADES |